Vanguard Group
ONCO icon

Vanguard Group’s Onconetix ONCO Stock Holding History

Vanguard Group’s Portfolio ONCO Stock Details ONCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$12.3K – 4371
2024
Q2 		– Hold
0
– – – 4383
2024
Q1 		– Hold
0
– – – 4419
2023
Q4 		– Sell
-1
Closed -$55.1K – 4463
2023
Q3 		$100K Hold
1
– – ﹤0.01% 4346
2023
Q2 		$200K Hold
1
– – ﹤0.01% 4316
2023
Q1 		$189K Buy
+1
New +$200K ﹤0.01% 4327
2022
Q4 		– Hold
0
– – – 4446
2022
Q3 		– Hold
0
– – – 4515

Other funds holding ONCO

Zurich Cantonal Bank
Zurich Cantonal Bank Zurich, Switzerland $52.2B AUM 40.82% 1-Year Est. Return
American Financial Group
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aspire Private Capital
Aspire Private Capital Cornelius, North Carolina $484M AUM 17.28% 1-Year Est. Return
Tower Research Capital (TRC)
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Vanguard Group's ONCO Position: Q3 2024 in Review

Vanguard Group held its Onconetix (ONCO) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4371.

Vanguard Group first reported a position in ONCO in Q1 2023 and has held it in 3 quarters since. The position peaked at $200K in Q2 2023. 5 funds tracked by Wall St. Rank hold ONCO as of Q3 2024.

  • Vanguard Group held 0 shares of Onconetix worth $0 as of Q3 2024.
  • Vanguard Group left its Onconetix share count unchanged in Q3 2024.
  • Onconetix made up ﹤0.01% of Vanguard Group's portfolio in Q3 2024, its #4371 holding.
  • Vanguard Group first reported a position in Onconetix in Q1 2023 and has held it in 3 quarters since.
  • Vanguard Group's Onconetix position peaked at $200K in Q2 2023.
  • 5 funds tracked by Wall St. Rank held Onconetix as of Q3 2024.

Based on Vanguard Group's 13F filing for Q3 2024, filed 13 Nov 2024.